Floatz logo

Eloxatin

Anaplastic Thyroid Carcinomas

Hospices Civils de LyonPhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

7 Active assets in the Anaplastic Thyroid Carcinomas cohort.

Asset / SponsorPhaseRating
Cyclophosphamide
Chongqing Precision Biotech Co., Ltd
Phase 2B
Fludarabine
Chongqing Precision Biotech Co., Ltd
Phase 2B
FLUOROURACILUM
Hospices Civils de Lyon
Phase 2CCC
Zimberelimab
Hospices Civils de Lyon
Phase 2CCC
Domvanalimab
Hospices Civils de Lyon
Phase 2CCC
Levoleucovorin
Hospices Civils de Lyon
Phase 2CCC
cd70-targeting car-t cells
Chongqing Precision Biotech Co., Ltd
Phase 1CC

Same molecule, other indications

Eloxatin is also rated in:

exocrine pancreatic carcinomaDormant
BBB
Indicative ·
78 / 100
View asset →
colon adenocarcinomaDormant
BBB
Indicative ·
77 / 100
View asset →
colorectal neoplasmDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →